Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1138-2026

Community Products, LLC recalls Rifton Equipment

Community Products, LLCRifton, NY, United StatesReported Jan 28, 2026 · 5 months ago
Legal News Analyst ·

Reason for recall

Potential for fraying on the body support strap.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Rifton Equipment, Low Base TRAM. Model/Catalog Number: K320. The TRAM is a powered lift device for transferring clients in a seated position or assisting in a sit-to-stand transfer and gait training. The low base variant includes smaller casters and lower base frame so that the legs fit underneath beds
    Catalog # Number

What the firm is doing

Community Products notified consignees via email on about 12/18/2025. Consignees were instructed to notify all customers, if further distributed, of the recall, inspect all affected devices for visible fraying, and cease use if any is observed. Consignees were requested to provide contact information for the individual responsible for performing the replacement. If devices were further distributed, consignees were advised to manage all customer outreach, inspection and replacement. The other option was to provide Community Products with customer contact information, and Rifton will manage the process. Lastly, consignees were requested to confirm receipt of the notification.

DistributionShow details

Worldwide distribution - US Nationwide and the countries of UAE, Australia, Canada, EU, Israel, Hong Kong, Japan, Korea, New Zealand, Russia, Saudi Arabia, and UK.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls